Total Payments
$45,694
2024 Payments
$11,447
Companies
7
Transactions
28
Payment Breakdown by Category
Consulting$42,718 (93.5%)
Other$2,500 (5.5%)
Food & Beverage$476.07 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $42,718 | 17 | 93.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 5.5% |
| Food and Beverage | $476.07 | 10 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TISSUETECH, INC. | $26,615 | 9 | $0 (2021) |
| Oyster Point Pharma, Inc. | $15,141 | 10 | $0 (2024) |
| OCULUS, Inc. | $2,500 | 1 | $0 (2018) |
| TearLab Corp | $1,152 | 1 | $0 (2021) |
| ABBVIE INC. | $145.14 | 1 | $0 (2024) |
| MacuLogix, Inc. | $93.87 | 5 | $0 (2019) |
| Quidel Corporation | $47.51 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,447 | 7 | Oyster Point Pharma, Inc. ($11,302) |
| 2023 | $52.21 | 1 | Oyster Point Pharma, Inc. ($52.21) |
| 2022 | $3,834 | 4 | Oyster Point Pharma, Inc. ($3,787) |
| 2021 | $27,767 | 10 | TISSUETECH, INC. ($26,615) |
| 2019 | $75.28 | 4 | MacuLogix, Inc. ($75.28) |
| 2018 | $2,519 | 2 | OCULUS, Inc. ($2,500) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,636.25 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 05/31/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 03/15/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,291.15 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 03/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $145.14 | General |
| Category: EYE CARE | ||||||
| 03/01/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $3,587.85 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 02/02/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $1,109.75 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 01/05/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug) | Consulting Fee | Cash or cash equivalent | $701.50 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 09/29/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $52.21 | General |
| Category: DRY EYE | ||||||
| 10/31/2022 | Quidel Corporation | InflammaDry (Device) | Food and Beverage | In-kind items and services | $47.51 | General |
| Category: Eye Health | ||||||
| 08/03/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,533.00 | General |
| Category: DRY EYE | ||||||
| 06/15/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DRY EYE | ||||||
| 02/23/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,231.25 | General |
| Category: DRY EYE | ||||||
| 12/20/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 12/20/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 11/04/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $114.68 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 07/13/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 07/13/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 04/30/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 04/28/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/16/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/11/2021 | TearLab Corp | TearLab Osmolarity System (Device) | Consulting Fee | Cash or cash equivalent | $1,152.33 | General |
| Category: Diagnostics | ||||||
| 02/11/2021 | TISSUETECH, INC. | PROKERA (Device), AMNIOGRAFT | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 06/28/2019 | MacuLogix, Inc. | AdaptDx (Device) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Diagnostic Instrument | ||||||
| 05/03/2019 | MacuLogix, Inc. | AdaptDx (Device) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Diagnostic Instrument | ||||||
| 02/21/2019 | MacuLogix, Inc. | AdaptDx (Device) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diagnostic Instrument | ||||||
About John Rumpakis, O.D., M.B.A
John Rumpakis, O.D., M.B.A is a Optometrist healthcare provider based in Lake Oswego, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841395449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Rumpakis, O.D., M.B.A has received a total of $45,694 in payments from pharmaceutical and medical device companies, with $11,447 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($42,718).
Ad
Practice Information
- Specialty Optometrist
- Location Lake Oswego, OR
- Active Since 09/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841395449
Products in Payments
- PROKERA (Device) $26,615
- RYZUMVI (Drug) $11,302
- TYRVAYA (Drug) $3,839
- OCULUS Keratograph 5M (Device) $2,500
- TearLab Osmolarity System (Device) $1,152
- LUMIGAN (Drug) $145.14
- AdaptDx (Device) $93.87
- InflammaDry (Device) $47.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lake Oswego
David Wolf, O.d, O.D
Optometrist — Payments: $5,709
Optometrist $5,709
Kyle Palmer
Optometrist — Payments: $5,632
Optometrist $5,632
Dr. Joseph Neron, Od, OD
Optometrist — Payments: $3,130
Optometrist $3,130
Rachel Horrocks, O.d, O.D
Optometrist — Payments: $3,005
Optometrist $3,005
Dr. Daniel Robison, Od, OD
Optometrist — Payments: $1,761
Optometrist $1,761
Dr. Stephen Olsen, O.d, O.D
Optometrist — Payments: $923.63
Optometrist $923.63